PDIA6 (protein disulfide isomerase family A member 6) functions as a multifaceted chaperone in the endoplasmic reticulum with critical roles in protein folding homeostasis and disease progression. PDIA6 forms Ca2+-dependent multichaperone condensates in the ER lumen that recruit essential folding machinery components including BiP, ERdj3, PDIA1, and Grp94, enhancing protein folding efficiency and preventing misfolding 1. The protein exhibits dual regulatory functions in cellular stress responses, acting as a chaperone that inhibits protein aggregation while negatively regulating the unfolded protein response through interactions with UPR sensors. Dysregulated PDIA6 expression contributes significantly to multiple disease states. In pancreatic cancer, PDIA6 promotes cell proliferation and immune evasion, with its upregulation mediated by RBM47 binding to its 3'-UTR region 2. Similarly, PDIA6 expression is elevated in prostate adenocarcinoma, where knockdown substantially reduces cancer cell proliferation 3. In breast cancer, increased PDIA6 expression correlates with lymph node metastasis and tumor aggressiveness 4. Additionally, PDIA6 plays a protective role against oxidative stress-induced cellular senescence, as its targeting by miR-181a contributes to hydrogen peroxide-mediated cellular damage 5. PDIA6 has also been implicated in diabetes pathogenesis, where it inhibits pancreatic β-cell proliferation and promotes apoptosis 6.